Related Experiment Video
Updated: Sep 30, 2025
The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
ENDO-ACAB EARLY POSTOPERATIVE PERIOD RESULTS: ANALYSIS AND COMPARISON
B Oniani1, T Shaburishvili1, K Beselia1
11Tbilisi Heart and Vascular Clinic; Georgia.
Insights
Endoscopic atraumic coronary artery bypass grafting (EndoACAB) offers a novel approach to treating ischemic heart disease. Early outcomes in Georgia demonstrate comparable results to international centers, indicating successful implementation.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Cardiac Procedures
- Ischemic Heart Disease Management
Background:
- Coronary artery bypass grafting (CABG) is a standard treatment for ischemic heart disease.
- Endoscopic atraumic coronary artery bypass grafting (EndoACAB) presents a less invasive alternative.
- Evaluating the early outcomes of EndoACAB is crucial for its adoption.
Purpose of the Study:
- To analyze the early postoperative outcomes of EndoACAB performed in Georgia.
- To compare these outcomes with data from leading international cardiothoracic centers.
- To assess the safety and efficacy of this novel procedure in a new setting.
Main Methods:
- Retrospective analysis of 162 patients who underwent EndoACAB between 2015 and 2017.
- Collection and review of preoperative, intraoperative, and early postoperative data.
- Statistical comparison of outcomes with international benchmarks.
Main Results:
- No intraoperative mortality observed.
- Early postoperative mortality rate was 1.2%.
- Conversion to traditional CABG occurred in 2.5% of cases. Common complications included pneumonia (0.6%) and atrial fibrillation (1.9%). No surgical wound infections or strokes were recorded. Mean hospital stay was 4.8 days.
- Outcomes and mortality rates were comparable to international centers.
Conclusions:
- Endoscopic atraumic coronary artery bypass grafting (EndoACAB) has been successfully implemented in Georgia.
- The early postoperative results are consistent with those reported by leading international cardiothoracic centers.
- EndoACAB is a viable and safe option for treating ischemic heart disease.
Abstract:
Endoscopic atraumic coronary artery bypass grafting (EndoACAB) is a novel approach in the treatment of ischemic heart disease compared to traditional coronary artery bypass grafting (CABG). Analyzing the early and late outcome of EndoACAB is very important. EndoACAB was performed in "Tbilisi Heart and Vascular Clinic" for the first time in Georgia in 2015. The study aim was to analyze early postoperative period results and compare them with the research carried out at some leading international cardiothoracic centers. 162 patients underwent EndoACAB in 2015-2017. We studied preoperative and intraoperative characteristics of patients as well as early postoperative outcome. No intraoperative mortality was detected. Lethal outcome in early postoperative period was seen in 1,2%. Intraoperative switch from Endo-ACAB to CABG was seen in 2,5%. Pneumon was diagnosed in 0.6%, atrial fibrillation and flutter - 1,9%, no surgical wound infection nor stroke was detected. mean days of hospital stay was 4,8 days±1.2. There was no statistically significant difference in our results and mortality rate compared to the results of foreign referral centers. We assume that EndoACAB which is a novelty for Georgian medical society is successfully implemented and its early outcome is the same as operations performed in leading international centers.
